Skip to content

iDose TR
Support & Resources

See below for information and resources to help get you started with iDose TR.

iDose TR was proven safe and effective in clinical studies—8 of 10 people were completely free of prescription eye drops at 12 months with iDose TR.

Linda’s iDose TR story

Learn how Linda, a real iDose TR patient, took control of her eye pressure with iDose TR.

Check out our iDose TR Copay Program

Check out our iDose TR Copay Program, where eligible commercially insured people may pay as little as $0*
Eligibility requirements include, but are not limited to:

  • Having commercial insurance coverage
  • Living in the United States, including US Territories  
  • Being age 18 or older on the date of the iDose TR procedure 

*iDose TR Copay Program is available for commercially insured eligible patients only. Additional restrictions may apply. Subject to change; click for full terms and conditions

Insurance education

Care can be costly, especially for an ongoing condition like glaucoma or ocular hypertension. So we’ve created an insurance education guide that you can download below. Here’s an overview of insurance types and considerations.

  • Medicare: A federal government health insurance program for people 65 years of age or older and younger people with disabilities.
  • Medicaid: Joint federal and state program that helps cover medical costs for people with limited income and resources
  • Commercial insurance: This private insurance often comes through an employer-sponsored health insurance plan but can also be bought through the Affordable Care Act (ACA) marketplace

Choosing the right coverage can be confusing and challenging. Here are some questions to help you learn more about which plan might be best for you:

  • What does the insurance plan cover?
  • How much does the plan cost?
  • What are the plan’s limitations?
  • Is my current doctor covered by this plan?
  • What is this plan’s prescription drug coverage like?
  • Can I reduce my out-of-pocket responsibility?

Brochure

View and download a brochure about iDose TR so that you have all the information you need in one place.

Support groups for people with glaucoma and their care partners

More than 80 million people worldwide live with glaucoma. Shown below are support groups that offer information and resources for you and your family members. Just click on the logos to visit their websites.

Bright Foundation Logo Glaucoma Research Foundation logo Prevent Blindness logo The Glaucoma Foundation logo Vision Health Advocacy Coalition logo Caregiver Action Network Logo

Find a doctor near you

Interested in taking a proactive approach to treatment with iDose TR to help lower high eye pressure but don’t know where to start? The Find a Doctor tool can connect you with an eye doctor in your area who can guide you on your glaucoma treatment journey.

Important Safety Information

iDose TR is gently placed directly inside your eye by your eye doctor.

You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).

The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.

If you have additional questions, please contact your doctor. For full Prescribing Information click here.

Approved Uses

iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-888-404-1644.

Important Safety Information

iDose TR is gently placed directly inside your eye by your eye doctor.

You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).

The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.

If you have additional questions, please contact your doctor. For full Prescribing Information click here.

Approved Uses

iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-888-404-1644.

Eligibility, Terms, and Conditions

Patient eligibility requires enrollment in iDoseCareConnect and completion of a benefits investigation.

The iDose® TR Copay Assistance Program (“Program”) is available exclusively to patients with commercial (private or non-governmental) insurance who have a valid prescription for an FDA-approved use of iDose® TR.

Patients who use Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD), TRICARE, or any other federal or state government program (collectively, “Government Programs”) to pay for iDose® TR or related administration services are not eligible.

The Program is also invalid if all costs can be fully reimbursed by commercial insurance or other assistance programs.

Under the Program, patients may still be required to pay a co-pay. Depending on individual insurance coverage, out-of-pocket expenses for iDose® TR may be reduced to as little as $0 per calendar year. The exact out-of-pocket cost depends on the patient’s health insurance plan.

The Program helps cover the cost of iDose® TR and, where allowed by law, may also assist with eligible procedure costs directly related to its administration. Program benefits cannot exceed the patient’s actual out-of-pocket expenses for iDose® TR. This Program is not health insurance or a benefit plan; the patient’s non-governmental insurance remains the primary payer.

Once enrolled, the Program will honor claims for services rendered up to 180 days prior to the enrollment date. Claims must be submitted within 180 days of the date of service, unless otherwise specified.

Use of this Program must comply with all relevant health insurance requirements. Patients, pharmacies, physicians’ offices, and hospitals participating in the Program are responsible for reporting all Program benefits received, as required by insurers or the law.

Program benefits may not be sold, purchased, traded, or offered for sale.

The patient or their guardian must be at least 18 years old to receive assistance through the Program. The Program is valid only in the United States and U.S. Territories and is void where prohibited by law.

The Program’s value is intended solely for the benefit of the patient. Funds provided through the Program may only be used to reduce out-of-pocket costs for enrolled patients.

Patients must have commercial insurance and provide proof of financial responsibility for a portion of the drug and/or procedure cost, if applicable.

This offer cannot be combined with any other rebate, coupon, or similar offer for iDose® TR.

Glaukos reserves the right at any time to delete, modify, or change the terms, benefits, and conditions without notice.

docktor finder icon FIND A DOCTOR » Created with Sketch.